Copper deficiency exacerbates bile duct ligation-induced liver injury and fibrosis in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 339, Issue 1, 2011, Pages 298-306

  Song, Ming ^a   Zhou, Zhanxiang ^c   Chen, Theresa ^a   Zhang, Jingwen ^a   McClain, Craig J ^a,b  

^a University of Louisville School of Medicine   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CERULOPLASMIN; COLLAGEN; FERRITIN; HEME OXYGENASE 1; TETRATHIOMOLYBDIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT LIGATION; BIOGENESIS; CONTROLLED STUDY; COPPER DEFICIENCY; DISEASE EXACERBATION; DISEASE SEVERITY; DOWN REGULATION; FATTY ACID OXIDATION; GENE EXPRESSION; IRON OVERLOAD; IRON STORAGE; LIVER FIBROSIS; LIVER INJURY; MALE; MITOCHONDRION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION;

ANGIOGENESIS INHIBITORS; ANIMALS; BILE DUCTS; BLOTTING, WESTERN; BODY WEIGHT; CHOLESTASIS; COPPER; GLUTATHIONE; HEME OXYGENASE-1; IMMUNOHISTOCHEMISTRY; IRON; LIGATION; LIVER; LIVER CIRRHOSIS; LUNG INJURY; MALE; MOLYBDENUM; NUTRITIONAL STATUS; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; S-ADENOSYLMETHIONINE;

EID: 80053162290     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.111.184325     Document Type: Article

References (40)

1. Aigner E, Strasser M, Haufe H, Sonnweber T, Hohla F, Stadlmayr A, Solioz M, Tilg H, Patsch W, Weiss G, et al. (2010) A role for low hepatic copper concentrations in nonalcoholic fatty liver disease. Am J Gastroenterol 105:1978-1985.
2. Aigner E, Theurl I, Haufe H, Seifert M, Hohla F, Scharinger L, Stickel F, Mourlane F, Weiss G, and Datz C (2008) Copper availability contributes to iron perturbations in human nonalcoholic fatty liver disease. Gastroenterology 135:680-688.
3. Akkaoui M, Cohen I, Esnous C, Lenoir V, Sournac M, Girard J, and Prip-Buus C (2009) Modulation of the hepatic malonyl-CoA-carnitine palmitoyltransferase 1A partnership creates a metabolic switch allowing oxidation of de novo fatty acids. Biochem J 420:429-438.
4. Askari FK, Dick R, Mao M, and Brewer GJ (2004) Tetrathiomolybdate therapy protects against concanavalin A and carbon tetrachloride hepatic damage in mice. Exp Biol Med (Maywood) 229:857-863. (Pubitemid 39166492)
5. Atamna H, Walter PB, and Ames BN (2002) The role of heme and iron-sulfur clusters in mitochondrial biogenesis, maintenance, and decay with age. Arch Biochem Biophys 397:345-353. (Pubitemid 34852302)
6. Barrow L and Tanner MS (1989) The effect of carbon tetrachloride on the copper-laden rat liver. Br J Exp Pathol 70:9-19. (Pubitemid 19077043)
7. Bergheim I, Guo L, Davis MA, Duveau I, and Arteel GE (2006) Critical role of plasminogen activator inhibitor-1 in cholestatic liver injury and fibrosis. J Pharmacol Exp Ther 316:592-600. (Pubitemid 43130985)
8. Brewer GJ, Dick R, Ullenbruch MR, Jin H, and Phan SH (2004) Inhibition of key cytokines by tetrathiomolybdate in the bleomycin model of pulmonary fibrosis. J Inorg Biochem 98:2160-2167. (Pubitemid 39488145)
9. Brewer GJ, Ullenbruch MR, Dick R, Olivarez L, and Phan SH (2003) Tetrathiomolybdate therapy protects against bleomycin-induced pulmonary fibrosis in mice. J Lab Clin Med 141:210-216. (Pubitemid 36324239)
10. Bonham M, O'Connor JM, Hannigan BM, and Strain JJ (2002) The immune system as a physiological indicator of marginal copper status? Br J Nutr 87:393-403. (Pubitemid 34575561)
11. Deering TB, Dickson ER, Fleming CR, Geall MG, McCall JT, and Baggenstoss AH (1977) Effect of D-penicillamine on copper retention in patients with primary billiary cirrhosis. Gastroenterology 72:1208-1212. (Pubitemid 8116684)
12. DiSilvestro RA and Carlson GP (1991) Effects of moderate copper deficiency on carbon tetrachloride-induced hepatotoxicity in rats. Proc Soc Exp Biol Med 197: 32-35.
13. Domitrović R, Jakovac H, Grebić D, Milin C, and Radosević-Stasić B (2008) Doseand time-dependent effects of luteolin on liver metallothioneins and metals in carbon tetrachloride-induced hepatotoxicity in mice. Biol Trace Elem Res 126:176-185.
14. Falkenberg M, Gaspari M, Rantanen A, Trifunovic A, Larsson NG, and Gustafsson CM (2002) Mitochondrial transcription factors B1 and B2 activate transcription of human mtDNA. Nat Genet 31:289-294.
15. Fields M, Ferretti RJ, Smith JC Jr, and Reiser S (1984) The interaction of type of dietary carbohydrates with copper deficiency. Am J Clin Nutr 39:289-295. (Pubitemid 14186430)
16. Fontanesi F, Soto IC, and Barrientos A (2008) Cytochrome c oxidase biogenesis: new levels of regulation. IUBMB Life 60:557-568.
17. Gallagher CH, Reeve VE, and Wright R (1973) Copper deficiency in the rat. Effect on the ultrastructure of hepatocytes. Aust J Exp Biol Med Sci 51:181-189.
18. Gozzelino R, Jeney V, and Soares MP (2010) Mechanisms of cell protection by heme oxygenase-1. Annu Rev Pharmacol Toxicol 50:323-354.
19. Harris ZL, Durley AP, Man TK, and Gitlin JD (1999) Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc Natl Acad Sci U S A 96:10812-10817. (Pubitemid 29442226)
20. Harvey LJ and McArdle HJ (2008) Biomarkers of copper status: a brief update. Br J Nutr 99:S10-S13. (Pubitemid 351936561)
21. Johnson WT and DeMars LC (2004) Increased heme oxygenase-1 expression during copper deficiency in rats results from increased mitochondrial generation of hydrogen peroxide. J Nutr 134:1328-1333. (Pubitemid 38720702)
22. Kostiuk MA, Corvi MM, Keller BO, Plummer G, Prescher JA, Hangauer MJ, Bertozzi CR, Rajaiah G, Falck JR, and Berthiaume LG (2008) Identification of palmitoylated mitochondrial proteins using a bio-orthogonal azido-palmitate analogue. FASEB J 22:721-732. (Pubitemid 351348125)
23. Lin H, Yu CH, Jen CY, Cheng CF, Chou Y, Chang CC, and Juan SH (2010) Adiponectin-mediated heme oxygenase-1 induction protects against iron-induced liver injury via a PPARα dependent mechanism. Am J Pathol 177:1697-1709.
24. -ΔΔCt method. Methods 25:402-408.
25. Ma S, Hou G, Dick RD, and Brewer GJ (2004) Tetrathiomolybdate protects against liver injury from acetaminophen in mice. J Appl Res Clin Exp Ther 4:419-426. (Pubitemid 39299386)
26. Okado-Matsumoto A and Fridovich I (2001) Subcellular distribution of superoxide dismutases (SOD) in rat liver: Cu,Zn-SOD in mitochondria. J Biol Chem 276: 38388-38393.
27. Panteghini M (1990) Aspartate aminotransferase isoenzymes. Clin Biochem 23:311-319.
28. Piantadosi CA, Carraway MS, Babiker A, and Suliman HB (2008) Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via Nrf2-mediated transcriptional control of nuclear respiratory factor-1. Circ Res 103:1232-1240.
29. Poss KD and Tonegawa S (1997) Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci U S A 94:10919-10924. (Pubitemid 27430836)
30. Prohaska JR (1991) Changes in Cu,Zn-superoxide dismutase, cytochrome c oxidase, glutathione peroxidase and glutathione transferase activities in copper-deficient mice and rats. J Nutr 121:355-363.
31. Rodríguez-Moreno F, González-Reimers E, Santolaria-Fernández F, Galindo-Martín L, Hernandez-Torres O, Batista-López N, and Molina-Perez M (1997) Zinc, copper, manganese, and iron in chronic alcoholic liver disease. Alcohol 14:39-44. (Pubitemid 27052108)
32. Schaff Z, Lapis K, Szende B, Jeney A, Gergely P, Simon K, Divald A, Timár F, and Major J (1991) The effect of D-penicillamine on CCl4-induced experimental liver cirrhosis. Exp Pathol 43:111-120.
33. Schosinsky KH, Lehmann HP, and Beeler MF (1974) Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride. Clin Chem 20:1556-1563.
34. Shalev A, Siegrist-Kaiser CA, Yen PM, Wahli W, Burger AG, Chin WW, and Meier CA (1996) The peroxisome proliferator-activated receptor α is a phosphoprotein: regulation by insulin. Endocrinology 137:4499-4502. (Pubitemid 26321901)
35. Song M, Song Z, Barve S, Zhang J, Chen T, Liu M, Arteel GE, Brewer GJ, and McClain CJ (2008) Tetrathiomolybdate protects against bile duct ligation-induced cholestatic liver injury and fibrosis. J Pharmacol Exp Ther 325:409-416. (Pubitemid 351574799)
36. Uhlikova E, Kupcova V, Szantova M, and Turecky L (2008) Plasma copper and ceruloplasmin in patients with alcoholic liver steatosis. Bratisl Lek Listy 109:431-433.
37. Yao P, Nussler A, Liu L, Hao L, Song F, Schirmeier A, and Nussler N (2007) Quercetin protects human hepatocytes from ethanol-derived oxidative stress by inducing heme oxygenase-1 via the MAPK/Nrf2 pathways. J Hepatol 47:253-261. (Pubitemid 47023137)
38. Yeligar SM, Machida K, and Kalra VK (2010) Ethanol-induced HO-1 and NQO1 are differentially regulated by HIF-1α and Nrf2 to attenuate inflammatory cytokine expression. J Biol Chem 285:35359-35373.
39. Yu J, Chu ES, Wang R, Wang S, Wu CW, Wong VW, Chan HL, Farrell GC, and Sung JJ (2010) Heme oxygenase-1 protects against steatohepatitis in both cultured hepatocytes and mice. Gastroenterology 138:694-704.
40. Yun N, Eum HA, and Lee SM (2010) Protective role of heme oxygenase-1 against liver damage caused by hepatic ischemia and reperfusion in rats. Antioxid Redox Signal 13:1503-1512.